Used TradersYard?Share your experience to help other traders. The review form is underneath the company profile ↓
T
Unclaimed profile
Austria
TradersYard is an Austria-based simulated prop trading firm offering 1-Step, 2-Step and Instant Funding programmes across forex, commodities, indices, stocks, ETFs, cryptocurrencies and futures. Current programmes provide up to $300K simulated capital and a tiered profit split that can reach 100% on the first $300 of profits. Rules and programme terms can change; always verify current details directly with TradersYard.
Trader Tools scoreNew
User rating—0 reviews
Rank#50
Max allocationUp to $300K
PlatformsTradersYard platform; MT5 coming soon
MarketsForex, commodities, indices, stocks, ETFs, crypto, futures
Firm typeSimulated multi-asset prop firm
Profit split100% first $300; 90% to $1K; 80% above $1K
Scaling planUp to $300K simulated allocation
LeverageProgramme dependent
Drawdown typeProgramme-specific daily and max drawdown
First payoutAfter reward eligibility is met
Payout frequencyProgramme dependent
News tradingProgramme dependent
Weekend holdingProgramme dependent
EA / automationProgramme rules apply
Copy tradingProgramme rules apply
Consistency ruleProgramme dependent
Evaluation typesInstant Funding, 1-Step, 2-Step
Account sizesUp to $300K
Minimum trading daysProgramme dependent
Refund / reset policyCurrent challenge terms apply
Legal entityTradersYard GmbH, Vienna, Austria
Reward processingMost rewards processed within 4-6 business hours
Trader Tools offer
Visit FirmVisit for offers
TradersYard Review 2026
Looking for a TradersYard review? Compare its current trading rules, payout terms, platforms, account sizes and, where available, approved Trader Tools user ratings below.
TradersYard does not yet have an approved Trader Tools user review. You can still compare the factual profile details below and add a review if you have used the firm.
You need to log in before leaving a review.
User reviews
Reviews use structured questions only. Trader Tools does not publish user-written review text.
No approved reviews yet.